Press Releases


  • Announcement by the Ministry of Health on the decisions of the Council of Ministers for the use of updated, adapted vaccines against COVID-19 , 15-09-2022
  • Announcement by the Ministry of Health regarding discontinuance of free COVID-19 rapid testing in August , 12-08-2022
  • Announcement by the Ministry of Health on the decisions of the Council of Ministers , 14-07-2022
  • Council of Ministers decides on reintroduction of masks indoors as of 8 July , 06-07-2022
  • Announcement by the Ministry of Health on the decisions of the Council of Ministers , 28-06-2022
  • Announcement by the Ministry of Health on the epidemiological situation in relation with COVID-19 , 24-06-2022
  • Changes to the operating hours of COVID-19 vaccination centres , 30-05-2022
  • Clarifications by the Ministry of Health on the decisions of the Council of Ministers which enter into force as of 1 June 2022 , 30-05-2022
  • Action Plan for the smooth operation of flights and the operation of airports and ports, to be abolished , 27-05-2022
  • Announcement by the Ministry of Health on the decisions of the Council of Ministers - 27 May 2022 , 27-05-2022
  • Call centre for the management of COVID-19 cases and contacts, launched by the Ministry of Health , 19-05-2022
  • Changes to the operating hours of the Vaccination Centres against COVID-19 , 18-05-2022
  • Announcement of the Ministry of Health on the obligation to use a mask indoors , 16-05-2022
  • Announcement of the Ministry of Health on the decisions of the Council of Ministers which enter into force as of 15 May 2022 , 13-05-2022
  • Availability of Paxlovid for prescription to patients with mild/moderate COVID-19 disease , 11-05-2022
  • Announcement by the Ministry of Health on the administration of a booster/4th dose to vulnerable groups of the population , 10-05-2022
  • Statement by the Minister of Health regarding the decisions of the Council of Ministers for further relaxations on the restrictive measures against COVID-19 , 10-05-2022
  • Administration of a booster/4th dose to persons over 60 years of age , 22-04-2022
  • Readjustment plan on restrictions against COVID-19, as of 22 April 2022 , 22-04-2022
  • Setting of a maximum price limit on COVID-19 self-test package , 21-04-2022
  • Issuance of the vaccination and recovery EUDCC European Digital Certificate for Turkish Cypriots , 20-04-2022
  • Statement by the Minister of Health regarding the decisions of the Council of Ministers , 20-04-2022
  • Administration of a booster/4th dose through appointment or through walk-in vaccination centres , 19-04-2022
  • Readjustment Plan on Restrictions against COVID-19, as of 18 April 2022 , 19-04-2022
  • New Action Plan for smooth operation of flights and operation of airports enters into force as of 18 April , 18-04-2022
  • As of 18 April 2022, Cyprus abolishes FlightPass, country categorization and most travel-related protocols , 14-04-2022
  • Operating hours and places of vaccination centres for the administration of the booster/4th dose of the vaccine to persons of 70 years and over , 12-04-2022
  • Extension of the platform for the issuance of an EUDCC European Digital Certificate for gradual coverage of Turkish Cypriots based on age criteria , 11-04-2022
  • Announcement by the Ministry of Health on the administration of the booster/4th dose of the vaccine to persons aged 70 years and over , 11-04-2022
  • Epidemiological risk assessment of countries concerning COVID-19, dated 11/04/2022 , 11-04-2022
  • Clarifications on the decisions of the Council of Ministers regarding the relaxation of measures , 11-04-2022
  • New Action Plan for the smooth operation of flights and the operation of airports, as of 18 April 2022 , 07-04-2022
  • Statement by the Minister of Health regarding the decisions of the Council of Ministers - relaxation of measures , 07-04-2022
  • Epidemiological risk assessment of countries concerning COVID-19, dated 04/04/2022 , 04-04-2022
  • Announcement by the Ministry of Health on the administration of the booster vaccine dose against COVID-19 , 29-03-2022
  • Announcement of the Ministry of Health on the release of positive COVID-19 cases , 28-03-2022
  • Epidemiological risk assessment of countries concerning COVID-19, dated 28/03/2022 , 28-03-2022
  • Announcement by the Ministry of Health regarding the 25th March parade , 24-03-2022
  • Announcement by the Ministry of Health on the decisions of the Council of Ministers regarding COVID-19 vaccine boosters , 22-03-2022
  • Epidemiological risk assessment of countries concerning COVID-19, dated 21/03/2022 , 21-03-2022
  • Decisions of the Council of Ministers on the new Covid-19 measures , 16-03-2022
  • Recommendations of the National Vaccination Advisory Committee of the Ministry of Health , 14-03-2022
  • Epidemiological risk assessment of countries concerning COVID-19, dated 14/03/2022 , 14-03-2022
  • Distribution of 3rd package of free COVID-19 self-tests continues , 09-03-2022
  • Announcement by the Ministry of Health for the implementation of the “test to stay” measure in the Education Service , 09-03-2022
  • Epidemiological risk assessment of countries concerning COVID-19, dated 07/03/2022 , 09-03-2022
  • Announcement by the Ministry Health on the release of close contacts who have not been isolated from a COVID-19 positive case , 08-03-2022
  • Appointment availability for the Nuvaxovid vaccine via the vaccination portal , 08-03-2022
  • Readjustment plan on restrictions against COVID-19 , 08-03-2022
  • Guidelines by the Ministry of Health for the release of positive COVID-19 cases , 07-03-2022
  • Statement by the Minister of Health on the decisions of the Council of Ministers , 03-03-2022
  • Readjustment plan regarding measures against COVID-19 , 03-03-2022
  • Operation of a Vaccination Centre in Larnaka Old Hospital as replacement of the Larnaka Port Vaccination Centre , 25-02-2022
  • What changes in the check of the European Digital Covid Certificates (EUDCC) through the CovScanCyprus application , 24-02-2022
  • Clarifications on a special protocol for catering and entertainment establishments , 23-02-2022
  • Distribution of free of charge self-tests for COVID-19 in pharmacies , 23-02-2022
  • Rapid Antigen Testing Units – 23 February 2022 , 22-02-2022
  • Rapid Antigen Testing Units – 22 February 2022 , 21-02-2022
  • As of 21 February 2022, the new Action Plan for the smooth operation of flights and the operation of airports enters into force , 18-02-2022
  • Rapid Antigen Testing Units – 21 February 2022 , 18-02-2022
  • Rapid Antigen Testing Units – 20 February 2022 , 18-02-2022
  • Rapid Antigen Testing Units – 19 February 2022 , 18-02-2022
  • Changes to the operating hours of the Vaccination Centres as of Monday 21 February 2022 , 18-02-2022
  • Rapid Antigen Testing Units – 18 February 2022 , 17-02-2022
  • Reminder to beneficiaries on the distribution of self-test kits for COVID-19 , 16-02-2022
  • Clarifications about the lifting of the ban on entry to various venues by unvaccinated persons or persons who have not completed their vaccination , 16-02-2022
  • Rapid Antigen Testing Units – 17 February 2022 , 16-02-2022
  • As of 21 February 2022, the new Action Plan for the smooth operation of flights and the operation of airports enters into force , 15-02-2022
  • Statement by the Minister of Health on the decisions of the Council of Ministers , 15-02-2022
  • Rapid Antigen Testing Units – 16 February 2022 , 15-02-2022
  • Rapid Antigen Testing Units – 15 February 2022 , 14-02-2022
  • Rapid Antigen Testing Units – 14 February 2022 , 11-02-2022
  • Rapid Antigen Testing Units – 13 February 2022 , 11-02-2022
  • Rapid Antigen Testing Units – 12 February 2022 , 11-02-2022
  • Rapid Antigen Testing Units – 11 February 2022 , 10-02-2022
  • Rapid Antigen Testing Units – 10 February 2022 , 09-02-2022
  • Rapid Antigen Testing Units – 9 February 2022 , 08-02-2022
  • COVID-19 vaccination portal software upgraded , 07-02-2022
  • European COVID-19 Digital Certificate including booster dose for Turkish Cypriots , 07-02-2022
  • Rapid Antigen Testing Units – 8 February 2022 , 07-02-2022
  • Rapid Antigen Testing Units – 7 February 2022 , 05-02-2022
  • Rapid Antigen Testing Units – 6 February 2022 , 04-02-2022
  • Rapid Antigen Testing Units – 5 February 2022 , 04-02-2022
  • Change of operating hours of the vaccination centres against COVID-19 as of 7 February 2022 , 03-02-2022
  • Rapid Antigen Testing Units – 4 February 2022 , 03-02-2022
  • Announcement by the Ministry of Health regarding the decisions of the Council of Ministers , 02-02-2022
  • Rapid Antigen Testing Units – 3 February 2022 , 02-02-2022
  • Clarifications by the Ministry of Health on the procedure for implementing the measure “test to stay” in primary and secondary education , 01-02-2022
  • Rapid Antigen Testing Units – 2 February 2022 , 01-02-2022
  • Rapid Antigen Testing Units – 1 February 2022 , 31-01-2022
  • Start of a review concerning the conduct of studies at Synchron Research Services, India , 31-01-2022
  • Rapid Antigen Testing Units – 31 January 2022 , 28-01-2022
  • Rapid Antigen Testing Units – 29 January 2022 , 28-01-2022
  • Rapid Antigen Testing Units – 28 January 2022 , 28-01-2022
  • Frequently Asked Questions - CovScan , 27-01-2022
  • Reminder regarding the use of the CovScan Cyprus application , 27-01-2022
  • Vaccinations of children aged 5-11 in cooperation with the Paediatric Society of Cyprus , 26-01-2022
  • Announcement by the Ministry of Health regarding the decisions of the Council of Ministers , 26-01-2022
  • Rapid Antigen Testing Units – 27 January 2022 , 26-01-2022
  • Rapid Antigen Testing Units – 26 January 2022 , 25-01-2022
  • Announcement by the Ministry of Health regarding changes to ‘test-to-stay’ measure in schools – testing units at schools , 24-01-2022
  • Rapid Antigen Testing Units – 25 January 2022 , 24-01-2022
  • Reduction of close contacts’ self-isolation period as of 24 January 2022 , 22-01-2022
  • Rapid Antigen Testing Units – 24 January 2022 , 22-01-2022
  • Rapid Antigen Testing Units – 23 January 2022 , 22-01-2022
  • Rapid Antigen Testing Units – 22 January 2022 , 22-01-2022
  • Answers to citizens’ enquiries about the process of entering data on Phase platform , 21-01-2022
  • Clarifications regarding the EUDCC Recovery Certificate following the announcements of the Council of Ministers of 21 December 2021 , 20-01-2022
  • Distribution of free of charge self-tests for COVID-19 continues in pharmacies , 20-01-2022
  • European COVID-19 Digital Certificate, including booster dose, for Turkish Cypriots , 20-01-2022
  • The Council of Ministers approved the new Action Plan for the smooth operation of flights and the operation of airports , 19-01-2022
  • European COVID-19 Digital Certificate including booster dose , 19-01-2022
  • Rapid Antigen Testing Units – 20 January 2022 , 19-01-2022
  • The use of EUDCC certificates is temporarily revoked for persons who have tested positive to COVID-19 , 19-01-2022
  • latest safety data provide reassurance about use of mRNA vaccines during pregnancy , 19-01-2022
  • Announcement by the Ministry of Health for the Vaccination Plan against COVID-19 , 17-01-2022
  • Rapid Antigen Testing Units – 19 January 2022 , 17-01-2022
  • Rapid Antigen Testing Units – 18 January 2022 , 17-01-2022
  • Rapid Antigen Testing Units – 17 January 2022 , 14-01-2022
  • Rapid Antigen Testing Units – 16 January 2022 , 14-01-2022
  • Rapid Antigen Testing Units – 15 January 2022 , 14-01-2022
  • Changes to the Release Protocol and introduction of an automated release procedure , 14-01-2022
  • Rapid antigen testing units - 14 January 2022 , 14-01-2022
  • Rapid antigen testing units – 13 January 2022 , 13-01-2022
  • Announcement by the Minister of Health, Mr Michalis Hadjipantela, on the decisions of the Council of Ministers , 12-01-2022
  • Option for a 24-hour rapid test for passengers travelling to the Republic of Cyprus , 12-01-2022
  • Rapid antigen testing units – 12 January 2022 , 12-01-2022
  • Rapid antigen testing units – 11 January 2022 , 10-01-2022
  • Updated instructions for management of COVID-19 cases and their close contacts , 10-01-2022
  • Rapid antigen testing units – 10 January 2022 , 10-01-2022
  • Rapid antigen testing units – 9 January 2022 , 09-01-2022
  • Rapid antigen testing units – 8 January 2022 , 08-01-2022
  • Rapid antigen testing units – 7 January 2022 , 07-01-2022
  • Clarifications on the decisions of the Council of Ministers — 5 January 2022 , 06-01-2022
  • Statement by the Minister of Health, Mr Michalis Hadjipantela, on the decisions of the Council of Ministers , 05-01-2022
  • Rapid antigen testing units – 6 January 2022 , 05-01-2022
  • Rapid antigen testing units – 5 January 2022 , 04-01-2022
  • Revised operating hours of Ammochostos Vaccination Centre — Change of self-test availability hours at Lemesos Maternity Centre , 04-01-2022
  • Rapid antigen testing units – 4 January 2022 , 04-01-2022
  • Rapid antigen testing units – 3 January 2022 , 03-01-2022
  • Rapid antigen testing units – 2 January 2022 , 02-01-2022
  • Rapid antigen testing units – 1 January 2022 , 01-01-2022
  • Epidemiological risk assessment of countries concerning COVID-19, dated 31/12/2021 , 31-12-2021
  • Clarifications on the decisions of the Council of Ministers for containing the spread of COVID-19 , 31-12-2021
  • Statement by the Minister of Health, Mr Michalis Hadjipantela, on the decisions of the Council of Ministers , 29-12-2021
  • Rapid antigen testing units – 30 December 2021 , 29-12-2021
  • Rapid antigen testing units – 29 December 2021 , 29-12-2021
  • Vaccinations of children aged 5-11 years in cooperation with the Cyprus Paediatric Society , 28-12-2021
  • Free of charge self-tests for Cypriot citizen beneficiaries or residents of Cyprus who are not registered in the GHS , 28-12-2021
  • Citizens may update the COVID-19 Positive Cases Data Entry Platform , 28-12-2021
  • Rapid antigen testing units – 28 December 2021 , 28-12-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 27/12/2021 , 27-12-2021
  • Rapid antigen testing units – 27 December 2021 , 26-12-2021
  • Rapid antigen testing units – 23 December 2021 , 23-12-2021
  • Clarifications on the decisions of the Council of Ministers for containing the spread of COVID-19 , 22-12-2021
  • Administration of the 3rd/booster dose available to students at all walk-in centres on 27 and 28 December , 22-12-2021
  • Rapid antigen testing units – 22 December 2021 , 22-12-2021
  • Statement by the Minister of Health following a meeting of the Council of Ministers – Decisions on new measures , 21-12-2021
  • Rapid antigen testing units – 21 December 2021 , 21-12-2021
  • Free COVID-19 self-tests for citizens, as of 21 December , 20-12-2021
  • Temporary operation of Latsia Vaccination Centre only for scheduled appointments , 20-12-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 20/12/2021 , 20-12-2021
  • Rapid antigen testing units – 20 December 2021 , 20-12-2021
  • Rapid antigen testing units – 19 December 2021 , 19-12-2021
  • Announcement by the Ministry of Health for passengers entering the Republic of Cyprus from the United Kingdom as of 18 December , 18-12-2021
  • Rapid antigen testing units – 18 December 2021 , 18-12-2021
  • What changes regarding the checks of European Digital COVID Certificate (EUDCC) through the application CovScan Cyprus , 17-12-2021
  • Rapid antigen testing units – 17 December 2021 , 17-12-2021
  • Rapid antigen testing units – 16 December 2021 , 16-12-2021
  • Automated check of citizens through the CovScan Cyprus application, as of 18 December , 15-12-2021
  • Rapid antigen testing units – 15 December 2021 , 15-12-2021
  • Interval before COVID-19 booster shot reduced to five months and two weeks , 14-12-2021
  • Clarifications on the decisions of the Council of Ministers — 13 December 2021 , 13-12-2021
  • Statement by the Minister of Health on the decisions of the Council of Ministers regarding the pandemic , 13-12-2021
  • Rapid antigen testing units – 14 December 2021 , 13-12-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 13/12/2021 , 13-12-2021
  • Rapid antigen testing units – 13 December 2021 , 13-12-2021
  • Self-tests will be available in pharmacies free of charge as of 20 December , 12-12-2021
  • Rapid antigen testing units – 12 December 2021 , 12-12-2021
  • The Vaccination Portal is available for vaccination appointments with the 2nd dose of the Johnson & Johnson vaccine , 10-12-2021
  • Rapid antigen testing units – 11 December 2021 , 10-12-2021
  • EMA and ECDC recommendations on heterologous vaccination courses against COVID-19 , 10-12-2021
  • Rapid antigen testing units – 10 December 2021 , 10-12-2021
  • Rapid antigen testing units – 9 December 2021 , 08-12-2021
  • Administration of the booster/3rd dose of the vaccine against COVID-19 for individuals aged 18 and over , 07-12-2021
  • Rapid antigen testing units – 8 December 2021 , 07-12-2021
  • EMA recommends approval for use of RoActemra in adults with severe COVID-19 , 07-12-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 06/12/2021 , 06-12-2021
  • Rapid antigen testing units – 6 December 2021 , 06-12-2021
  • Rapid antigen testing units – 5 December 2021 , 04-12-2021
  • Rapid antigen testing units – 4 December 2021 , 03-12-2021
  • Rapid antigen testing units – 3 December 2021 , 03-12-2021
  • Statement by the Minister of Health, Mr Michalis Hadjipantela, following a meeting of the Council of Ministers – Decisions on new measures , 02-12-2021
  • Passengers aged 12 years and over are obliged to carry out a PCR test upon arrival in Cyprus , 02-12-2021
  • Rapid antigen testing units – 2 December 2021 , 02-12-2021
  • Rapid antigen testing units – 1 December 2021 , 01-12-2021
  • Rapid antigen testing units – 30 November 2021 , 30-11-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 29/11/2021 , 29-11-2021
  • Administration of the booster/3rd dose of the vaccine against COVID-19 for individuals aged 30 and over , 29-11-2021
  • Rapid antigen testing units – 29 November 2021 , 29-11-2021
  • Rapid antigen testing units – 28 November 2021 , 28-11-2021
  • Rapid antigen testing units – 27 November 2021 , 27-11-2021
  • Clarifications by the Ministry of Health on the new measures to contain the pandemic , 26-11-2021
  • Entry to the Republic restricted due to new SARS-COV-2 virus strain , 26-11-2021
  • Rapid antigen testing units – 26 November 2021 , 25-11-2021
  • Statement by the Minister of Health, Mr Michalis Hadjipantela, on the decisions of the Council of Ministers on measures to contain the pandemic , 24-11-2021
  • Rapid antigen testing units – 24 November 2021 , 23-11-2021
  • EMA evaluating data on booster dose of COVID-19 Vaccine Janssen , 23-11-2021
  • Rapid antigen testing units – 23 November 2021 , 23-11-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 22/11/2021 , 22-11-2021
  • EMA starts review of Paxlovid for treating patients with COVID-19 , 22-11-2021
  • EMA issues advice on use of Lagevrio (molnupiravir) for the treatment of COVID-19 , 22-11-2021
  • Rapid antigen testing units – 22 November 2021 , 22-11-2021
  • Rapid antigen testing units – 20 November 2021 , 20-11-2021
  • EMA receives application for marketing authorisation for Xevudy (sotrovimab) for treating patients with COVID-19 , 19-11-2021
  • Rapid antigen testing units – 19 November 2021 , 19-11-2021
  • Extension of working hours at walk-in vaccination centres , 19-11-2021
  • Rapid antigen testing units – 18 November 2021 , 18-11-2021
  • SafePass possession checks via the CovScan application will be mandatory as of 22 November , 17-11-2021
  • EMA receives application for conditional marketing authorisation of Novavax’s COVID-19 vaccine, Nuvaxovid , 17-11-2021
  • Rapid antigen testing units – 17 November 2021 , 17-11-2021
  • Administration of a booster dose for individuals aged 40 years and over, begins , 16-11-2021
  • Walk-in vaccination centre to operate at Europe Square in Larnaka, on Saturday, 20 November , 16-11-2021
  • Rapid antigen testing units – 16 November 2021 , 16-11-2021
  • Council of Ministers: Administration of a booster dose of a COVID-19 vaccine for the population aged 18 years and over , 15-11-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 15/11/2021 , 15-11-2021
  • Rapid antigen testing units – 15 November 2021 , 15-11-2021
  • Rapid antigen testing units – 14 November 2021 , 14-11-2021
  • Rapid antigen testing units – 13 November 2021 , 13-11-2021
  • COVID-19: EMA recommends authorisation of two monoclonal antibody medicines , 12-11-2021
  • Rapid antigen testing units – 12 November 2021 , 12-11-2021
  • Rapid antigen testing units – 11 November 2021 , 11-11-2021
  • Special leave of absence granted to employees who are vaccinated with a booster dose of the COVID-19 vaccine , 10-11-2021
  • EMA starts evaluating use of COVID-19 vaccine Spikevax in children aged 6 to 11 , 10-11-2021
  • COVID-19: EMA and Heads of Medicines Agencies update on molnupiravir , 10-11-2021
  • Rapid antigen testing units – 10 November 2021 , 10-11-2021
  • Rapid antigen testing units – 9 November 2021 , 09-11-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 08/11/2021 , 08-11-2021
  • Rapid antigen testing units – 8 November 2021 , 08-11-2021
  • Rapid antigen testing units – 7 November 2021 , 07-11-2021
  • Rapid antigen testing units – 6 November 2021 , 06-11-2021
  • Booster dose administration procedure for people who were vaccinated with Johnson&Johnson vaccine, for diabetics and for people aged 50 and over , 05-11-2021
  • Rapid antigen testing units – 5 November 2021 , 05-11-2021
  • SafePass possession checks via the CovScan application will be optional until 22 November , 05-11-2021
  • Extension of measures against the spread of COVID-19 — A booster dose available for people over 50 and for individuals with severe obesity , 04-11-2021
  • Questions and answers on end of rolling review for antibodies bamlanivimab and etesevimab for COVID-19 , 04-11-2021
  • EMA ends rolling review of the antibodies bamlanivimab and etesevimab for COVID-19 following withdrawal by Lilly , 04-11-2021
  • Rapid antigen testing units – 4 November 2021 , 04-11-2021
  • Rapid antigen testing units – 3 November 2021 , 03-11-2021
  • Home administration of a booster dose of the vaccine against COVID-19 to bedridden patients , 02-11-2021
  • Rapid antigen testing units – 2 November 2021 , 02-11-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 01/11/2021 , 01-11-2021
  • Rapid antigen testing units – 1 November 2021 , 01-11-2021
  • Rapid antigen testing units – 31 October 2021 , 31-10-2021
  • Rapid antigen testing units – 30 October 2021 , 30-10-2021
  • Announcement of the Deputy Ministry of Research, Innovation and Digital Policy for the issuance of a European Digital COVID Certificate to Turkish Cypriots , 29-10-2021
  • Rapid antigen testing units – 29 October 2021 , 29-10-2021
  • Rapid antigen testing units – 28 October 2021 , 28-10-2021
  • Extension of measures against the spread of COVID-19 — A booster dose available for individuals vaccinated with J&J , 27-10-2021
  • Rapid antigen testing units – 27 October 2021 , 27-10-2021
  • COVID-19: EMA starts rolling review of molnupiravir , 26-10-2021
  • Spikevax: EMA recommendation on booster dose , 26-10-2021
  • Rapid antigen testing units – 26 October 2021 , 26-10-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 25/10/2021 , 25-10-2021
  • Rapid antigen testing units – 25 October 2021 , 25-10-2021
  • Rapid antigen testing units – 24 October 2021 , 24-10-2021
  • Rapid antigen testing units – 23 October 2021 , 23-10-2021
  • Rapid antigen testing units – 22 October 2021 , 22-10-2021
  • Rapid antigen testing units – 21 October 2021 , 21-10-2021
  • Rapid antigen testing units – 20 October 2021 , 20-10-2021
  • Rapid antigen testing units – 19 October 2021 , 19-10-2021
  • Management of COVID-19 cases and their close contacts , 19-10-2021
  • Vaccinations with the 3rd dose begin for people aged 60 years and over , 18-10-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 18/10/2021 , 18-10-2021
  • Rapid antigen testing units – 18 October 2021 , 18-10-2021
  • Rapid antigen testing units – 17 October 2021 , 17-10-2021
  • Rapid antigen testing units – 16 October 2021 , 16-10-2021
  • Council of Ministers: The age limit for the administration of the booster/3rd dose is reduced to 60 and new vulnerable groups are added , 15-10-2021
  • Rapid antigen testing units – 15 October 2021 , 15-10-2021
  • Rapid antigen testing units – 14 October 2021 , 14-10-2021
  • EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG , 13-10-2021
  • Vaccination portal reopens as of 15 October for arrangement of vaccination appointments with 1st and 3rd doses , 13-10-2021
  • Rapid antigen testing units – 13 October 2021 , 13-10-2021
  • Ministry of Health proceeds with the administration of the 3rd dose of COVID-19 vaccine to persons 65 years of age and older , 12-10-2021
  • EMA receives application for marketing authorisation for ronapreve (casirivimab / imdevimab) for treatment and prevention of COVID-19 , 12-10-2021
  • Rapid antigen testing units – 12 October 2021 , 12-10-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 11/10/2021 , 11-10-2021
  • Rapid antigen testing units – 11 October 2021 , 11-10-2021
  • Rapid antigen testing units – 10 October 2021 , 10-10-2021
  • Rapid antigen testing units – 9 October 2021 , 09-10-2021
  • Decisions of the Council of Ministers on restrictive measures against the spread of COVID-19 , 08-10-2021
  • Rapid antigen testing units – 8 October 2021 , 08-10-2021
  • Large walk-in center for citizens’ vaccination to operate in Lemesos on 10 October , 07-10-2021
  • Vaccination Portal at the disposal of people aged 70 years and over as of 8 October , 07-10-2021
  • Rapid antigen testing units – 7 October 2021 , 07-10-2021
  • Rapid antigen testing units – 6 October 2021 , 06-10-2021
  • SafePass will be issued only for fully vaccinated individuals as of October 18 , 05-10-2021
  • Vaccination proceeds with the administration of a 3rd dose to individuals aged 75 and over , 05-10-2021
  • Rapid antigen testing units – 5 October 2021 , 05-10-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 4/10/2021 , 04-10-2021
  • Comirnaty and Spikevax: EMA recommendations on extra doses and boosters , 04-10-2021
  • Rapid antigen testing units – 4 October 2021 , 04-10-2021
  • Rapid antigen testing units – 3 October 2021 , 03-10-2021
  • Vaccination Portal opens for 3rd dose vaccination appointments , 02-10-2021
  • Rapid antigen testing units – 2 October 2021 , 02-10-2021
  • Rapid antigen testing units – 1 October 2021 , 01-10-2021
  • Rapid antigen testing units – 30 September 2021 , 30-09-2021
  • Rapid antigen testing units – 29 September 2021 , 29-09-2021
  • Announcement of the Deputy Ministry of Research on the issuance of a European Digital COVID Certificate to Turkish Cypriots , 28-09-2021
  • Rapid antigen testing units – 28 September 2021 , 28-09-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 27/09/2021 , 27-09-2021
  • Rapid antigen testing units – 27 September 2021 , 27-09-2021
  • Rapid antigen testing units – 26 September 2021 , 26-09-2021
  • Rapid antigen testing units – 25 September 2021 , 25-09-2021
  • Rapid antigen testing units – 24 September 2021 , 24-09-2021
  • Vaccination with the 3rd dose for citizens aged 83 and over , 23-09-2021
  • Rapid antigen testing units – 23 September 2021 , 23-09-2021
  • Rapid antigen testing units – 22 September 2021 , 22-09-2021
  • Gradual vaccination with 3rd dose for individuals aged 65 and over to begin at walk-in vaccination centres , 21-09-2021
  • Rapid antigen testing units – 21 September 2021 , 21-09-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 20/09/2021 , 20-09-2021
  • Rapid antigen testing units – 20 September 2021 , 20-09-2021
  • Rapid antigen testing units – 19 September 2021 , 19-09-2021
  • Rapid antigen testing units – 18 September 2021 , 18-09-2021
  • Rapid antigen testing units – 17 September 2021 , 17-09-2021
  • Announcement of the Deputy Ministry of Research, Innovation and Digital Policy on the issuance of a European Digital COVID Certificate to Turkish Cypriots , 16-09-2021
  • Rapid antigen testing units – 16 September 2021 , 16-09-2021
  • Efforts to promote COVID-19 vaccination are intensifying , 15-09-2021
  • Rapid antigen testing units – 15 September 2021 , 15-09-2021
  • Rapid antigen testing units – 14 September 2021 , 14-09-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 13/09/2021 , 13-09-2021
  • Rapid antigen testing units – 13 September 2021 , 13-09-2021
  • Rapid antigen testing units – 12 September 2021 , 12-09-2021
  • Rapid antigen testing units – 11 September 2021 , 11-09-2021
  • Rapid antigen testing units – 10 September 2021 , 10-09-2021
  • Vaccination Centres re-open every Saturday for the best service of school and university students , 09-09-2021
  • Rapid antigen testing units – 9 September 2021 , 09-09-2021
  • Rapid antigen testing units – 8 September 2021 , 08-09-2021
  • Rapid antigen testing units – 7 September 2021 , 07-09-2021
  • Vaccination procedure with 3rd dose for specific groups of the population , 06-09-2021
  • EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty , 06-09-2021
  • New school year begins with mobile testing units in Secondary Education , 06-09-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 06/09/2021 , 06-09-2021
  • Rapid antigen testing units – 6 September 2021 , 06-09-2021
  • Rapid antigen testing units – 5 September 2021 , 05-09-2021
  • Rapid antigen testing units – 4 September 2021 , 04-09-2021
  • Rapid antigen testing units – 3 September 2021 , 03-09-2021
  • ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines , 02-09-2021
  • Rapid antigen testing units – 2 September 2021 , 02-09-2021
  • Rapid antigen testing units – 1 September 2021 , 01-09-2021
  • CovScan Cyprus application at the service of citizens and businesses , 31-08-2021
  • Rapid antigen testing units – 31 August 2021 , 31-08-2021
  • Announcement by the Deputy Ministry of Research on the issuance of the EU Digital COVID Certificate to Turkish Cypriots , 30-08-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 30/8/2021 , 30-08-2021
  • Rapid antigen testing units – 30 August 2021 , 30-08-2021
  • Rapid antigen testing units – 29 August 2021 , 29-08-2021
  • Rapid antigen testing units – 28 August 2021 , 28-08-2021
  • Rapid antigen testing units – 27 August 2021 , 27-08-2021
  • Rapid antigen testing units – 26 August 2021 , 26-08-2021
  • Rapid antigen testing units – 25 August 2021 , 25-08-2021
  • Rapid antigen testing units – 24 August 2021 , 24-08-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 23/8/2021 , 23-08-2021
  • Rapid antigen testing units – 23 August 2021 , 23-08-2021
  • Rapid antigen testing units – 22 August 2021 , 22-08-2021
  • Rapid antigen testing units – 21 August 2021 , 21-08-2021
  • Rapid antigen testing units – 20 August 2021 , 20-08-2021
  • Rapid antigen testing units – 19 August 2021 , 19-08-2021
  • Rapid antigen testing units – 18 August 2021 , 18-08-2021
  • Announcement by the Deputy Ministry of Research, Innovation and Digital Policy for the issuance of the EU Digital COVID Certificate to Turkish Cypriots , 17-08-2021
  • Rapid antigen testing units – 17 August 2021 , 17-08-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 16/8/2021 , 16-08-2021
  • Rapid antigen testing units – 16 August 2021 , 16-08-2021
  • Rapid antigen testing units – 14 August 2021 , 14-08-2021
  • Clarifications regarding free rapid antigen tests for pregnant women who are not recommended for vaccination for medical reasons , 13-08-2021
  • Request for Issuance of a Certificate of approval for free rapid antigen tests for COVID-19 , 13-08-2021
  • Rapid antigen testing units – 13 August 2021 , 13-08-2021
  • EUDCC – EU Digital Certificate format required for all passengers as of 13 August , 12-08-2021
  • Rapid antigen testing units – 12 August 2021 , 12-08-2021
  • Rapid antigen testing units – 11 August 2021 , 11-08-2021
  • Rapid antigen testing units – 10 August 2021 , 10-08-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 9/8/2021 , 09-08-2021
  • Rapid antigen testing units – 9 August 2021 , 09-08-2021
  • Rapid antigen testing units – 8 August 2021 , 08-08-2021
  • Rapid antigen testing units – 7 August 2021 , 07-08-2021
  • Rapid antigen testing units – 6 August 2021 , 06-08-2021
  • Rapid antigen testing units – 5 August 2021 , 05-08-2021
  • Full vaccination is key to protecting against serious COVID-19, EMA and ECDC say , 05-08-2021
  • Guidelines by the Minister of Transport regarding means of Public Transport , 04-08-2021
  • Revised guidelines for the discharge of positive cases without symptoms or with mild symptoms , 04-08-2021
  • Rapid antigen testing units – 4 August 2021 , 04-08-2021
  • Vaccination of non-registered citizens or beneficiaries of the General Healthcare System through the “walk-in” centres , 03-08-2021
  • Reminder of the procedure for the approval of requests for free rapid antigen tests, by way exception, for medical reasons , 03-08-2021
  • Rapid antigen testing units – 3 August 2021 , 03-08-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 2/8/2021 , 02-08-2021
  • Rapid antigen testing units – 2 August 2021 , 02-08-2021
  • Rapid antigen testing units – 1 August 2021 , 01-08-2021
  • Reminder regarding the population groups that can perform rapid tests through the testing units of the Ministry of Health , 31-07-2021
  • Rapid antigen testing units – 31 July 2021 , 31-07-2021
  • Answers to Frequently Asked Questions on the decisions of the Council of Ministers , 30-07-2021
  • Vaccination procedure for minors aged 12 to 17 , 30-07-2021
  • Procedure for issuing a certificate by way of exception, allowing for a free rapid antigen test to a person who cannot be vaccinated for medical reasons , 30-07-2021
  • Statement by the Minister of Health, Mr Michalis Hadjipantela, on the Council of Ministers’ decisions , 30-07-2021
  • Rapid antigen testing units – 30 July 2021 , 30-07-2021
  • Rapid antigen testing units – 29 July 2021 , 29-07-2021
  • Rapid antigen testing units – 28 July 2021 , 28-07-2021
  • Issuance of EU Digital COVID Certificate and SafePass to individuals who have been vaccinated or have tested positive for covid in countries outside the EU, EEA or Switzerland , 27-07-2021
  • Rapid antigen testing units – 27 July 2021 , 27-07-2021
  • Change of the criteria regarding the conduct of a PCR laboratory test for COVID–19 upon arrival at the airports , 26-07-2021
  • Answers to frequently asked questions about rapid antigen tests as of 1st of August , 26-07-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 26/07/2021 , 26-07-2021
  • Rapid antigen testing units – 26 July 2021 , 26-07-2021
  • Rapid antigen testing units – 25 July 2021 , 25-07-2021
  • Rapid antigen testing units – 24 July 2021 , 24-07-2021
  • Rapid antigen testing units – 23 July 2021 , 23-07-2021
  • COVID-19 Vaccine Janssen: Guillain-Barré syndrome listed as a very rare side effect , 23-07-2021
  • Scheduling of appointments for vaccination against COVID-19 through the telephone lines of the Ministry of Health , 22-07-2021
  • Rapid antigen testing units – 22 July 2021 , 22-07-2021
  • Issuance of the EU Digital COVID Certificate for individuals who have been vaccinated or have tested positive for the virus in countries outside the EU, EEA or Switzerland , 21-07-2021
  • Rapid antigen testing units – 21 July 2021 , 21-07-2021
  • Administration of 2nd dose of covid vaccine in Cyprus to individuals who have been vaccinated with 1st dose abroad , 20-07-2021
  • Rapid antigen testing units – 20 July 2021 , 20-07-2021
  • Guidelines by the Minister of Transport for persons employed in means of Public Transport and for passengers , 19-07-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 19/07/2021 , 19-07-2021
  • Rapid antigen testing units – 19 July 2021 , 19-07-2021
  • Rapid antigen testing units – 18 July 2021 , 18-07-2021
  • Operation of hotlines for the rescheduling of appointments for the administration of the 2nd dose , 17-07-2021
  • Rapid antigen testing units – 17 July 2021 , 17-07-2021
  • Incentives provided to young people by companies and organisations to promote vaccinations , 16-07-2021
  • Statements by the Commissioner for the Citizen on the incentives to increase vaccination coverage , 16-07-2021
  • Answers to frequently asked questions about the decisions of the Council of Ministers, dated 16 July 2021 , 16-07-2021
  • Statement by the Minister of Health, Mr Michalis Hadjipantela, on the Council of Ministers’ decisions for containing the pandemic , 16-07-2021
  • Address by the President of the Republic, Mr Nicos Anastasiades , 16-07-2021
  • Rapid antigen testing units – 16 July 2021 , 16-07-2021
  • Rapid antigen testing units – 15 July 2021 , 15-07-2021
  • Access of citizens to vaccination is facilitated through "walk-in" vaccination centres , 14-07-2021
  • Rapid antigen testing units – 14 July 2021 , 14-07-2021
  • Answers to frequently asked questions about the vaccines against COVID-19 by the Pharmaceutical Services of the Ministry of Health , 13-07-2021
  • Rapid antigen testing units – 13 July 2021 , 13-07-2021
  • Answers to questions relating to the implementation and monitoring of the measures of the Quarantine Law Decree (No. 28), by the Data Protection Commissioner , 12-07-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 12/7/2021 , 12-07-2021
  • Rapid antigen testing units – 12 July 2021 , 12-07-2021
  • Rapid antigen testing units – 11 July 2021 , 11-07-2021
  • Rapid antigen testing units – 10 July 2021 , 10-07-2021
  • Vaccination procedure for persons aged 16 and 17 years , 09-07-2021
  • Reassessment of the measure for the operation of theatres, amphitheatres, cinemas and other performance halls from 13 July , 09-07-2021
  • Management of COVID-19 cases and their close contacts , 09-07-2021
  • EMA advises against use of COVID-19 Vaccine Janssen in people with history of capillary leak syndrome , 09-07-2021
  • Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis , 09-07-2021
  • Rapid antigen testing units – 9 July 2021 , 09-07-2021
  • Rapid antigen testing units – 8 July 2021 , 08-07-2021
  • Statement by the Minister of Health, Mr Michalis Hadjipantelas, on the decisions of the Council of Ministers , 07-07-2021
  • Rapid antigen testing units – 7 July 2021 , 07-07-2021
  • Rapid antigen testing units – 6 July 2021 , 06-07-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 5/7/2021 , 05-07-2021
  • Rapid antigen testing units – 5 July 2021 , 05-07-2021
  • Rapid antigen testing units – 4 July 2021 , 04-07-2021
  • Clarifications on the decisions of the Council of Ministers - July 2, 2021 , 03-07-2021
  • Rapid antigen testing units – 3 July 2021 , 03-07-2021
  • Statement by the Minister of Health, Mr Michalis Hadjipantelas, on the decisions of the Council of Ministers for reinforcing vaccination coverage , 02-07-2021
  • Rapid antigen testing units – 2 July 2021 , 02-07-2021
  • The Ministry of Health proceeds with vaccination of 16 and 17 year olds who are not registered in GeSY , 01-07-2021
  • Written Consent Document of Parents / Legal Guardians for Vaccination of Minors against COVID-19 , 01-07-2021
  • Effort to increase vaccination coverage continues – The target for the vaccination of 65% of the population with the 1st dose has been achieved , 01-07-2021
  • Rapid antigen testing units – 1 July 2021 , 01-07-2021
  • Presentation of the European Digital COVID Certificate , 30-06-2021
  • Rapid antigen testing units – 30 June 2021 , 30-06-2021
  • Rapid antigen testing units – 29 June 2021 , 29-06-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 28/06/2021 , 28-06-2021
  • The Ministry of Health proceeds with the vaccination of individuals aged 16 and 17 , 28-06-2021
  • Rapid antigen testing units – 28 June 2021 , 28-06-2021
  • Rapid antigen testing units – 27 June 2021 , 27-06-2021
  • Concern over low vaccination rate among young people - A possible setback would have catastrophic consequences , 26-06-2021
  • Rapid antigen testing units – 26 June 2021 , 26-06-2021
  • Rapid antigen testing units – 25 June 2021 , 25-06-2021
  • Results of strain sequencing tests show an increased presence of the Indian strain in the community , 24-06-2021
  • Digital COVID Certificate for travelling to Cyprus accepted as of 1st July 2021 , 24-06-2021
  • Rapid antigen testing units – 24 June 2021 , 24-06-2021
  • Rapid antigen testing units – 23 June 2021 , 23-06-2021
  • Rapid antigen testing units – 22 June 2021 , 22-06-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 21/06/2021 , 21-06-2021
  • Rapid antigen testing units – 20 June 2021 , 20-06-2021
  • Rapid antigen testing units – 19 June 2021 , 19-06-2021
  • Minister of Health: We will fight health crisis through vaccination and personal protection measures , 18-06-2021
  • Rapid antigen testing units – 18 June 2021 , 18-06-2021
  • Rapid antigen testing units – 17 June 2021 , 17-06-2021
  • Council of Ministers decides new easing of measures: presence of fans at games at 50% capacity and 10 persons per table in catering establishments , 16-06-2021
  • Rapid antigen testing units – 16 June 2021 , 16-06-2021
  • Measures implemented at the points of entry of the Republic of Cyprus in order to contain the entry of SARS-CoV-2 mutations , 15-06-2021
  • Rapid antigen testing units – 15 June 2021 , 15-06-2021
  • The pandemic will be treated effectively only through vaccination – Appointments available for all people over the age of 18 , 14-06-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 14/06/2021 , 14-06-2021
  • Rapid antigen testing units – 14 June 2021 , 14-06-2021
  • Rapid antigen testing units – 12 June 2021 , 12-06-2021
  • Vaxzevria COVID Vaccine – EMA advises against use in people with history of capillary leak syndrome , 11-06-2021
  • COVID-19 vaccines: Update on ongoing evaluation of myocarditis and pericarditis , 11-06-2021
  • Rapid antigen testing units – 11 June 2021 , 11-06-2021
  • Vaccination is our main weapon to exit the health crisis , 10-06-2021
  • Revised list of clinical laboratories conducting rapid antigen tests that meet the specifications of the Ministry of Health , 10-06-2021
  • Rapid antigen testing units – 10 June 2021 , 10-06-2021
  • Strategic restarting of the economy and of social activity – What changes as of 10 June 2021 , 09-06-2021
  • Rapid antigen testing units – 9 June 2021 , 09-06-2021
  • Rapid antigen testing units – 8 June 2021 , 08-06-2021
  • Issuance of SARS-CoV-2 Vaccination Certificate , 07-06-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 07/06/2021 , 07-06-2021
  • EMA raises awareness of clinical care recommendations to manage suspected thrombosis with thrombocytopenia syndrome , 07-06-2021
  • Rapid antigen testing units – 7 June 2021 , 07-06-2021
  • Rapid antigen testing units – 6 June 2021 , 06-06-2021
  • Rapid antigen testing units – 5 June 2021 , 05-06-2021
  • Wedding reception halls’ opening hours extended until 3am , 04-06-2021
  • Rapid antigen testing units – 4 June 2021 , 04-06-2021
  • Rescheduling of vaccination appointments for 7 June, due to PASYNOs strike , 04-06-2021
  • Announcement of the Ministry of Interior regarding the re-opening of checkpoints as of 4 June 2021 , 03-06-2021
  • Over 54% of the population has received the 1st dose of the vaccine – Schedule for the Vaccination Portal for the period 4-12 June , 03-06-2021
  • SafePass is mandatory in indoor spaces , 03-06-2021
  • Rapid antigen testing units – 3 June 2021 , 03-06-2021
  • Rapid antigen testing units – 2 June 2021 , 02-06-2021
  • Rapid antigen testing units – 1 June 2021 , 01-06-2021
  • Strategic restarting of the economy and of social activity – What changes as of 1 June 2021 , 31-05-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 31/05/2021 , 31-05-2021
  • Rapid antigen testing units – 31 May 2021 , 31-05-2021
  • Rapid antigen testing units – 29 May 2021 , 29-05-2021
  • Getting closer to the target for vaccination of 65% of the population with at least the first dose – Information on vaccination appointments , 29-05-2021
  • First COVID-19 vaccine approved for children aged 12 to 15 in EU , 28-05-2021
  • Answers to frequently asked questions on what changes as of 29 May 2021 , 28-05-2021
  • Rapid antigen testing units – 28 May 2021 , 28-05-2021
  • Insufficient data on use of inhaled corticosteroids to treat COVID-19 , 27-05-2021
  • Statement by the Minister of Health Mr Constantinos Ioannou on the decisions of the Council of Ministers regarding the pandemic , 27-05-2021
  • Rapid antigen testing units – 27 May 2021 , 27-05-2021
  • Announcement by the Ministry of Health on the recommendations of the Scientific Advisory Committee for the AstraZeneca vaccine , 26-05-2021
  • Citizens gradually informed about AstraZeneca 2nd dose rescheduling , 26-05-2021
  • Rapid antigen testing units – 26 May 2021 , 26-05-2021
  • Cyprus travel protocol for vaccinated travellers , 25-05-2021
  • Rapid antigen testing units – 25 May 2021 , 25-05-2021
  • Epidemiological risk assessment of countries concerning COVID-19, Dated 24/05/2021 , 24-05-2021
  • Rapid antigen testing units – 24 May 2021 , 24-05-2021
  • Vaccination coverage increases, the population is being shielded against COVID-19 , 23-05-2021
  • Rapid antigen testing units – 23 May 2021 , 23-05-2021
  • Threshold of half a million vaccinations surpassed - Schedule of appointments for 24-29 May , 22-05-2021
  • Rapid antigen testing units – 22 May 2021 , 22-05-2021
  • Vaxzevria COVID-19 Vaccine: Further advice on blood clots and low blood platelets , 21-05-2021
  • EMA issues advice on use of sotrovimab (VIR-7831) for treating COVID-19 , 21-05-2021
  • Rapid antigen testing units – 21 May 2021 , 21-05-2021
  • Sinopharm vaccine (BBIBP COVID-19) in the category of vaccines accepted by the Republic of Cyprus , 20-05-2021
  • Rapid antigen testing units – 20 May 2021 , 20-05-2021
  • Results of specialized tests for the sequencing of SARS-CoV-2 virus strains , 19-05-2021
  • Rapid antigen testing units – 19 May 2021 , 19-05-2021
  • Minister of Health: Vaccination and compliance with the precautionary measures will lead to the lifting of more restrictions , 18-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 18 May 2021 , 18-05-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 18/05/2021 , 18-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 17 May 2021 , 17-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 16 May 2021 , 16-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 15 May 2021 , 15-05-2021
  • Vaccinations are at a more advanced stage compared to the initial plan – The Vaccination Portal opens for ages 18-21 , 14-05-2021
  • Statement by the Minister of Health, Mr Constantinos Ioannou, on the decisions of the Council of Ministers , 14-05-2021
  • What changes as of 17 May in the framework of the strategy for the gradual resumption of the economy and social activity , 14-05-2021
  • Maximum number of 10 persons in homes and gatherings , 14-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 14 May 2021 , 14-05-2021
  • Clarifications on the SafePass recovery SMS for individuals who have been positive COVID-19 cases , 13-05-2021
  • AstraZeneca vaccine can be administered to individuals aged 20 years and over by their Personal Doctors , 13-05-2021
  • The vaccination plan now focuses on young people – Answers to basic questions , 13-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 13 May 2021 , 13-05-2021
  • Cyprus ranks 4th among EU member states in terms of administration of vaccine doses per 100 inhabitants , 12-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 12 May 2021 , 12-05-2021
  • Additional measures to allow experts to focus on COVID-19 activities , 11-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 11 May 2021 , 11-05-2021
  • The appointment process for the 20-29 age group proceeds at a faster pace – Vaccination coverage by District , 10-05-2021
  • Reminder as to the places where a ‟SafePassˮ is required , 10-05-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 10/05/2021 , 10-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 10 May 2021 , 10-05-2021
  • Declaration form - positive case , 10-05-2021
  • Vaccination Portal opens for people aged 29 and 30 , 09-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 9 May 2021 , 09-05-2021
  • Implementation of the ‟SafePassˮ Decision as of 10 May , 08-05-2021
  • Conditions applied to vaccinated passengers , 08-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 8 May 2021 , 08-05-2021
  • Schedule for the arrangement of vaccination appointments against COVID-19 on 8 and 9 May, ages 31-34 , 07-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 7 May 2021 , 07-05-2021
  • Answers to frequently asked questions on what changes as of 10 May 2021 , 06-05-2021
  • Opening of schools with physical presence – rapid test units for students , 06-05-2021
  • Vaccination Portal opens for vaccination appointments for people of 35 and 36 years of age , 06-05-2021
  • Statement by the Minister of Health, Mr Constantinos Ioannou, on the decisions to restart the economy and social activity , 06-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 6 May 2021 , 06-05-2021
  • Island-wide measures to combat the coronavirus pandemic – Effective from 10/05/2021 , 05-05-2021
  • The Pharmaceutical Services provide answers to frequently asked questions about the vaccines against COVID-19 , 05-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 5 May 2021 , 05-05-2021
  • Changes in the process of arranging appointments through the COVID-19 Vaccination Portal as of 06/05/2021 , 04-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 4 May 2021 , 04-05-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 03/05/2021 , 03-05-2021
  • Priority for vaccination against COVID-19 for the age group of 30-38 – Schedule for 4-7 May , 03-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 3 May 2021 , 01-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 1 May 2021 , 01-05-2021
  • Rapid antigen testing for employees and the general population – Testing units 30 April 2021 , 30-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 29 April 2021 , 29-04-2021
  • Revised list of laboratories conducting molecular tests for the new coronavirus (SARS-CoV-2) privately , 28-04-2021
  • Revised list of clinical laboratories conducting rapid antigen tests , 28-04-2021
  • Schedule for the arrangement of vaccination appointments against COVID-19 for April 29-30 and May 4th , 28-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 28 April 2021 , 28-04-2021
  • Vaccination against COVID-19 – Answers to frequently asked questions , 27-04-2021
  • Period of administration of 2nd dose of AstraZeneca vaccine reduced to eight weeks , 27-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 27 April 2021 , 27-04-2021
  • National Vaccination Plan is in progress – Schedule for the period of 27-29 April , 26-04-2021
  • Guidelines by the Minister of Transport, Communications and Works concerning Public and Private Transport , 26-04-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 26/4/2021 , 26-04-2021
  • Answers to frequently asked questions on the measures to contain the COVID-19 pandemic (Effective between 26 April and 9 May) , 26-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 26 April 2021 , 26-04-2021
  • Vaccination coverage of the population continues – 20% of citizens have been vaccinated with the 1st dose of the vaccine , 25-04-2021
  • The percentage of employees undergoing rapid antigen tests increases – Which categories of citizens are exempt from the obligation for testing , 24-04-2021
  • Statement by the Minister of Health, Mr Constantinos Ioannou, on the decisions of the Council of Ministers concerning the pandemic , 23-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 24 April 2021 , 23-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 23 April 2021 , 23-04-2021
  • Administration of the AstraZeneca vaccine by Personal Doctors to beneficiaries aged 30 and over , 22-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 22 April 2021 , 22-04-2021
  • Updated schedule for the period 22-25 April vaccination program against COVID-19 , 21-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 21 April 2021 , 21-04-2021
  • COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets , 20-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 20 April 2021 , 20-04-2021
  • Answers to frequently asked questions about coronavirus cases and close contacts , 19-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 19 April 2021 , 19-04-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 19/4/2021 , 19-04-2021
  • The implementation of the National Vaccination Plan continues – Appointments available for individuals aged 51-52 , 18-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 18 April 2021 , 18-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 17 April 2021 , 17-04-2021
  • Press conference on the next steps of the vaccination plan , 16-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 16 April 2021 , 16-04-2021
  • 200,000 vaccinations administered in Cyprus until today – Priority to 53-54 age group for vaccination appointments on 16-17 April , 15-04-2021
  • Rapid testing will be conducted nasally for the entire population , 15-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 15 April 2021 , 15-04-2021
  • Janssen vaccine will not be administered pending the completion of the investigation of thrombosis cases in the USA , 14-04-2021
  • AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets , 14-04-2021
  • No self-isolation required for close contacts who have been vaccinated , 14-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 14 April 2021 , 14-04-2021
  • Requests for the COVID-19 home vaccination of bedridden individuals end on 16 April , 13-04-2021
  • Schedule for the resumption of wedding and christening ceremonies , 13-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 13 April 2021 , 13-04-2021
  • Vaccination appointment programme for the period 13-17 April , 12-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 12 April 2021 , 12-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 11 April 2021 , 11-04-2021
  • Vaccination portal opens on Sunday for individuals belonging to specific vulnerable groups , 10-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 10 April 2021 , 10-04-2021
  • 15,000 appointments to be made available for the vaccination of individuals aged 57 and 58 , 09-04-2021
  • The British strain of the virus is dominant in the community of Cyprus - Detection of the English strain in 111 samples , 09-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 9 April 2021 , 09-04-2021
  • Access to the Vaccination Portal for the arrangement of appointments by individuals aged 59 and 60 , 09-04-2021
  • Change in the protocol for positive case tracing in schools , 08-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 8 April 2021 , 08-04-2021
  • AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets , 07-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 7 April 2021 , 07-04-2021
  • 19,378 appointments to be made available for the vaccination of persons aged 61 and over , 06-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 6 April 2021 , 06-04-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 5/4/2021 , 05-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 5 April 2021 , 05-04-2021
  • Vaccination Portal opens for individuals who use biological agents or other immunosuppressive medicines , 04-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 4 April 2021 , 04-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 3 April 2021 , 03-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 2 April 2021 , 02-04-2021
  • Rapid antigen testing for employees and the general population – Testing units 1 April 2021 , 01-04-2021
  • Passengers holding a vaccination certificate from the Republic of Cyprus will not have to self-isolate or undergo testing upon arrival in Cyprus , 31-03-2021
  • AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues , 31-03-2021
  • Vaccination Portal to be made available for people aged 64 and over, on 1 April , 31-03-2021
  • Statement by the Minister of Health, Mr Constantinos Ioannou, on the decisions of the Council of Ministers , 31-03-2021
  • Vaccination Portal available until 31 March for patients with Diabetes Mellitus and Severe Obesity , 31-03-2021
  • Operation of rapid antigen testing units in remote areas , 31-03-2021
  • Rapid antigen tests for Gymnasium students , 31-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 31 March 2021 , 31-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 30 March 2021 , 30-03-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 29/3/2021 , 29-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 29 March 2021 , 29-03-2021
  • Over 19,000 vaccination appointments for individuals with Diabetes Mellitus and Severe Obesity , 28-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 28 March 2021 , 28-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 27 March 2021 , 27-03-2021
  • Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna , 26-03-2021
  • EMA issues advice on use of regdanvimab for treating COVID-19 , 26-03-2021
  • COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases , 26-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 26 March 2021 , 26-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 25 March 2021 , 25-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 24 March 2021 , 24-03-2021
  • Written statement by the Minister of Health, Mr Constantinos Ioannou , 23-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 23 March 2021 , 23-03-2021
  • Ministry of Health: Careful compliance with health measures to avoid deterioration of epidemiological picture , 22-03-2021
  • A total of 310,000 individuals will have received at least the 1st dose of a vaccine by the beginning of May , 22-03-2021
  • Cyprus ranks first in Europe in terms of testing and 5th in the EU in terms of vaccination coverage , 22-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 22 March 2021 , 22-03-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 22/3/2021 , 22-03-2021
  • Rescheduling of postponed appointments for vaccination with the AstraZeneca vaccine , 21-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 21 March 2021 , 21-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 20 March 2021 , 20-03-2021
  • The Vaccination Portal will be made available for people aged 66 and over on 20 – 21 March , 19-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 19 March 2021 , 19-03-2021
  • AstraZeneca vaccinations to be carried out normally , 18-03-2021
  • COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets , 18-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 18 March 2021 , 18-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 17 March 2021 , 17-03-2021
  • Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues , 16-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 16 March 2021 , 16-03-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 15/3/2021 , 15-03-2021
  • Outdoor areas of catering establishments reopen in accordance with health protocol , 15-03-2021
  • Postponement of vaccinations with the AstraZeneca vaccine until 18 March , 15-03-2021
  • EMA’s Safety Committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events – further update , 15-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 15 March 2021 , 15-03-2021
  • Clarifications on the measures that will apply on Green Monday , 14-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 14 March 2021 , 14-03-2021
  • Answers to frequently asked questions on what changes as of 15 March , 13-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 13 March 2021 , 13-03-2021
  • Statement by the Minister of Health, Mr Constantinos Ioannou, on the decisions of the Council of Ministers regarding the pandemic , 12-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 12 March 2021 , 12-03-2021
  • Revised list of clinical laboratories conducting rapid antigen tests that meet the specifications of the Ministry of Health , 11-03-2021
  • EMA recommends COVID-19 Vaccine Janssen (Johnson&Johnson) for authorisation in the EU , 11-03-2021
  • Presentation of CovTracer-EN contact tracing application by the Ministry of Health and the Deputy Ministry of Research , 11-03-2021
  • High percentage of the British strain of the virus exists in Cyprus – Reduction of serious cases only through compliance with the measures , 11-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 11 March 2021 , 11-03-2021
  • COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue with batch used in Austria , 11-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 10 March 2021 , 10-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 9 March 2021 , 09-03-2021
  • Vaccination Portal to be made available for people aged 67 and over – 22,808 vaccination appointments , 08-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 8 March 2021 , 08-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 6 March 2021 , 06-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 5 March 2021 , 05-03-2021
  • EMA starts rolling review of the Sputnik V COVID-19 vaccine , 04-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 4 March 2021 , 04-03-2021
  • Mobile testing units in schools for the convenience of school staff and students , 03-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 3 March 2021 , 03-03-2021
  • EMA issues advice on use of REGN-COV2 antibody combination (casirivimab / imdevimab) , 02-03-2021
  • Vaccination Portal to be made available for people aged 69 and over – 17,496 vaccination appointments , 02-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 2 March 2021 , 02-03-2021
  • Cyprus, armed with the triptych “test-surveillance-vaccinations”, enters the new phase of the strategic lifting of measures , 01-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 1 March 2021 , 01-03-2021
  • Rapid antigen testing for employees and the general population – Testing units 28 February 2021 , 28-02-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 27/2/2021 , 27-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 27 February 2021 , 27-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 26 February 2021 , 26-02-2021
  • Answers to frequently asked questions on what changes as of 1 March , 25-02-2021
  • Statement by the Minister of Health, Mr Constantinos Ioannou, during the announcement of the decisions of the Council of Ministers , 25-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 25 February 2021 , 25-02-2021
  • The objectives of the National Vaccination Plan are being achieved – More than 64,000 vaccines have been administered by the 23rd February , 24-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 24 February 2021 , 24-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 23 February 2021 , 23-02-2021
  • As of 23 February, 16,904 vaccination appointments will be made available for people aged 71 and over , 22-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 22 February 2021 , 22-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 21 February 2021 , 21-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 20 February 2021 , 20-02-2021
  • COVID-19 Vaccination of specific categories of the population based on serious illness risk factors , 19-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 19 February 2021 , 19-02-2021
  • The Council of Ministers has approved the resumption of flights and re-opening of airports with additional security measures , 18-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 18 February 2021 , 18-02-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 17/2/2021 , 17-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 17 February 2021 , 17-02-2021
  • National Vaccination Plan for COVID-19: 9.096 appointments for persons aged 74 and over , 16-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 16 February 2021 , 16-02-2021
  • Over 402,000 rapid tests in the 1st half of February – Continuous surveillance of the epidemiological picture is the main aim , 16-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 15 February 2021 , 15-02-2021
  • Mandatory weekly screening with rapid antigen testing for the self-employed and domestic workers , 14-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 14 February 2021 , 13-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 13 February 2021 , 12-02-2021
  • Statement by the Minister of Health, Mr Constantinos Ioannou, at the press conference on the National Vaccination Plan for COVID-19 , 12-02-2021
  • EMA starts rolling review of CureVac’s COVID-19 vaccine (CVnCoV) , 12-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 12 February 2021 , 12-02-2021
  • 9,264 Vaccination appointments made available for people over the age of 76 , 11-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 11 February 2021 , 11-02-2021
  • Second phase of strategic gradual de-escalation of restrictive measures extended until 28 February , 10-02-2021
  • Clarifications regarding the administration of AstraZeneca vaccine to specific age groups , 10-02-2021
  • Rapid antigen testing for employees and the general population – Testing units 10 February 2021 , 10-02-2021
  • Third phase of the National Vaccination Plan for COVID-19 begins with appointments made available for people over the age of 79 , 09-02-2021
  • Rapid antigen testing for employees and the general population – Testing units, 9 February 2021 , 09-02-2021
  • Rapid antigen testing for employees and the general population is in progress at 59 units (Testing Units – 8 February 2021) , 08-02-2021
  • Rapid antigen testing for employees and the general population– Testing units , 07-02-2021
  • Rapid antigen testing for employees and the general population is in progress – Testing units , 06-02-2021
  • Cyprus ranks second among EU countries in terms of coronavirus testing , 05-02-2021
  • Rapid antigen testing for employees and the general population is in progress – Testing units , 05-02-2021
  • List of clinical laboratories conducting rapid COVID-19 antigen test for which no molecular confirmation is required , 05-02-2021
  • Rapid antigen testing for employees and the general population is in progress - Testing units , 04-02-2021
  • Revised list of private laboratories for the new coronavirus (SARS-CoV-2) molecular test , 04-02-2021
  • EMA starts rolling review of Novavax’s COVID-19 vaccine (NVX-CoV2373) , 04-02-2021
  • Decisions of the Council of Ministers regarding the reopening of the sports sector , 03-02-2021
  • Self-isolation for 72 hours and laboratory testing 72 hours after arrival for all passengers arriving in the Republic of Cyprus , 03-02-2021
  • Cabinet adopts decision for the reopening of indoor theatres and cinemas as of 8 February , 03-02-2021
  • Testing for employees returning to work on 8 February is in progress , 03-02-2021
  • Vaccination Portal to be made available to citizens over the age of 83 , 02-02-2021
  • Testing for employees returning to work on 8 February, begins , 01-02-2021
  • Vaccination appointments for citizens over the age of 84 – 7,790 vaccine doses administered during the week of 23-29 January , 30-01-2021
  • Rapid tests for employees and the general population continue – Information about testing units on 30 January 2021 , 29-01-2021
  • EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU , 29-01-2021
  • Answer to frequently-asked questions on COVID-19 Vaccine AstraZeneca , 29-01-2021
  • *Revised* - Answers to frequently asked questions on what changes as of 1 February, in the framework of the strategic lifting of measures to contain the COVID-19 pandemic , 29-01-2021
  • COVID-19 vaccine safety update for Comirnaty , 29-01-2021
  • First COVID-19 vaccine safety update published , 29-01-2021
  • Clarification of Comirnaty dosage interval , 29-01-2021
  • Vaccination Portal to be made available to citizens over the age of 86 as of 29 January – New appointments as of 1st February , 28-01-2021
  • Answers to frequently asked questions on what changes as of 1 February, in the framework of the strategic lifting of measures to contain the COVID-19 pandemic , 27-01-2021
  • The measures relating to flights and airports shall be extended until 1st March 2021 , 27-01-2021
  • Statement by the Minister of Health, Mr Constantinos Ioannou, during the announcement of the 1st phase of the strategic lifting of measures , 27-01-2021
  • Change of Contact Information for the Call Centre of the electronic platform "CyprusFlightPass" , 26-01-2021
  • Vaccination Portal to be made available to citizens over the age of 88 as of 27 January , 26-01-2021
  • Cost of the laboratory test (RT-PCR) for Covid-19 at Larnaka and Pafos airports , 21-01-2021
  • Revised procedure for arranging vaccination appointments for COVID-19 , 19-01-2021
  • Epidemiological risk assessment of countries concerning COVID-19, dated 16/1/2021 , 16-01-2021
  • (Revised**) Answers to frequently asked questions on measures to contain the COVID-19 pandemic , 15-01-2021
  • (Revised*) Answers to frequently asked questions on measures to contain the COVID-19 pandemic , 12-01-2021
  • EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca , 12-01-2021
  • Press release by the Deputy Ministry of Research, Innovation and Digital Policy on citizens' movements by exception , 09-01-2021
  • Answers to frequently asked questions on measures to contain the COVID-19 pandemic , 08-01-2021
  • Statement by Minister of Health Mr Constantinos Ioannou regarding the announcement of the new measures against the pandemic , 08-01-2021
  • EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU , 06-01-2021
  • Answers to frequently asked questions on COVID-19 Vaccine Moderna , 06-01-2021
  • Update on rolling review of AstraZeneca’s COVID-19 vaccine , 31-12-2020
  • Presence of persons in houses other than permanent residents is prohibited – Remote working for public/wider public sector , 29-12-2020
  • Updated list of categories of citizens with risk factors for serious illness by COVID-19 , 29-12-2020
  • Antigen detection tests (rapid tests) do not need to be confirmed with a PCR test , 28-12-2020